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We evaluated the mechanism of insulin and phorbol 
ester induction of the proto-oncogene c-fos  in Chinese 
hamster ovary fibroblasts stably transformed with 
high  levels of genes expressing normal or truncated 
human insulin receptors. Both insulin and the tumor- 
promoting phorbol ester phorbol 12-myristate  13-ace- 
tate (PMA) induced c-fos mRNA accumulation in cells 
expressing high numbers  of  normal  human insulin re- 
ceptors; PMA but not insulin was  effective  in the cells 
expressing the mutant receptor. Transient expression 
studies with plasmid constructions containing c-fos 5’- 
flanking sequences ligated to the bacterial chloram- 
phenicol acetyltransferase  gene indicated that se- 
quences corresppnding to the serum response element 
were required for induction of c-fos transcription by 
both insulin and PMA. The insulin-sensitive  cells con- 
tained a nuclear factor, presumably a protein, which 
bound specifically to this sequence of the c-fos gene; 
the apparent affinity of this factor to the normal  serum 
response element was not affected by prior treatment 
of the cells  with insulin or PMA. This c-fos binding 
factor may prove to  be important in the regulation of 
c-fos expression by insulin and activators of protein 
kinase C. 
Insulin is known to increase (1-10) as well as decrease (11- 
15) the levels of certain cellular mRNAs after  its addition to 
target cells.  We recently reported that insulin  stimulated the 
accumulation of mRNA for the proto-oncogene c-fos in 3T3- 
L1 adipocytes within 10 min, apparently acting through its 
own receptor (16).  Similar  induction of c-fos mRNA occurred 
in response to phorbol esters in  these cells, but the insulin 
response appeared to occur through  a  protein  kinase C-inde- 
pendent pathway. Responses of c-fos mRNA to both  agents 
were transient, were superinduced by cycloheximide, and were 
completely inhibited by actinomycin D, suggesting that  en- 
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hanced c-fos transcription was responsible for the mRNA 
accumulation. 
In  the  current study, we attempted  to determine whether 
the sequences in the c-fos 5”flanking region that are known 
to be involved in the c-fos response to serum in fibroblasts 
(17-19)  were the same as those involved in the responses to 
insulin and tumor-promoting phorbol esters. To do this, we 
transfected plasmid constructions  containing normal and ab- 
normal c-fos upstream sequences fused to  the gene for chlor- 
amphenicol acetyltransferase into stable Chinese hamster 
ovary (CHO)’ fibroblast lines expressing high levels of either 
normal or truncated human insulin receptors (20). Results of 
these studies indicate that the normal insulin receptor is 
necessary for the insulin induction of c-fos mRNA and  that 
four bases in the serum-response element (SRE), located 
between -299 and -320 in the murine c-fos upstream region 
(17-19), are required for  c-fos induction by both insulin and 
tumor-promoting phorbol esters. 
EXPERIMENTAL  PROCEDURES 
Cell Culture-CHO, CHO.hIR, CHO.T, and CH0.T-t cells (20) 
were a generous gift from Dr. R.  A. Roth,  Department of Pharmacol- 
ogy, Stanford University, Palo Alto, CA  94305. They were  grown in 
Ham’s  F12  medium supplemented with 10% fetal calf serum, gluta- 
mine (2 mM), penicillin (100 units/ml), and streptomycin (100 pg/ 
ml). For experiments involving induction of c-fos  mRNA, cells were 
grown to confluence and pretreated for 16 h with serum-free Dulbec- 
CO’S modified Eagle’s medium (DMEM) containing 1% (w/v) bovine 
serum albumin as described (16). 
RNA Isolation and Northern Analysis-For  gel blot analysis, total 
cellular RNA was isolated and analyzed on formaldehyde/agarose 
gels as described (21). Northern blots were hybridized with 5 X lo6 
cpm of heat-denatured 32P-labeled v-fos as described (16). 
Protein Kinase C Assay-Protein kinase C measurements were 
performed in 1% (v/v) Triton X-100 cellular extracts as described 
(22). 
Plasmids-The plasmids used in the tranfection experiments were 
constructed as described (19), with modifications as noted below. The 
“wild type” plasmid -356 fos-chloramphenicol acetyltransferase con- 
tained murine c-fos sequences extending from -356 to  +lo9 relative 
to  the transcription  initiation site ligated to  the bacterial chloram- 
phenicol acetyltransferase gene (19). The  mutant plasmid (2-4 pM12) 
contained the identical construction in which four G residues in the 
SRE had Seen converted to C residues (bases -305 and -306 in the 
top strand, and -313 and -314 in the bottom strand). Details of 
these plasmid constructions will  be published separately.’ 
DNA Transfectiom-CH0.T cells  were plated the day before trans- 
fection at a density of 1.5 X lo6 cells/lOO-mm plate in Hams’ F12 
supplemented medium without penicillin or streptomycin. Each plate 
was transfected with 10 pg  of plasmid DNA  which had been isolated 
by alkaline lysis and purified by two cesium-chloride-ethidium bro- 
mide gradient centrifugation steps (23). Transfections were carried 
out by a minor modification of the calcium phosphate procedure (24) 
followed by a glycerol shock (25), in which cells were treated with 
10% (v/v) glycerol in phosphate-buffered saline for 2 min at room 
temperature. For each transfection experiment, 30 plates of cells were 
used. Equal volumes of the same calcium phosphate precipitate and 
plasmid were added to each of 15 plates. The plates were incubated 
at 37 “C in complete F12  medium for 48 h  after the addition of DNA, 
at which time the cells were placed into serum-free Dulbecco’s  mod- 
ified  Eagle’s  medium  for 16 h as described (26). Phorbol 12-myristate 
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13-acetate (PMA, 1.6 pM in 0.01% dimethyl sulfoxide) or insulin (10 
milliunits/ml = about 70 nM) was added for 45 min, and then total 
RNA  was  isolated  from 5 plates per condition as described above. 
RNase  Protection  Assay-Plasmid  p149 (19), which contains mu- 
rine c-fos sequences from  -56 to  +lo9 cloned into pSP65 (27): was 
used to quantitate transfected gene products essentially as described 
(27). 
Gel Shift Analysis-Probes for gel shift analysis were prepared 
from -356 /os-chloramphenicol acetyltransferase or 2-4 pM12 as 
described (19). Nuclear extracts were prepared from CH0.T cells 
(and in one instance, 1321-N1 human  astrocytoma cells; see Ref. 28) 
grown to confluence and pretreated for 16 h in serum-free medium 
as described  above. Following the addition of hormones as indicated, 
the cells were washed  three times with 4 ml of ice-cold phosphate- 
buffered saline and then used  for the preparation  of  nuclear extracts 
as described (29). The nuclear extracts (4 pg of protein/reaction) 
were  allowed to bind  radiolabeled  probes as described (29) and then 
subjected to nondenaturing electrophoresis on 7% acrylamide gels as 
described (18). The gels were then dried and subjected to autoradi- 
ography. 
RESULTS 
Exposure of the  CH0.T cell line, which expresses  approxi- 
mately 5 X 105-106 normal  human insulin  receptors/cell, to 
10 milliunits/ml  insulin  for 30 min  resulted in  the increased 
accumulation of c-fos mRNA when  compared to  control (Fig. 
1). In  contrast, insulin had  no effect in identical experiments 
on  the cell line CH0.T-t, which expresses similar  numbers of 
insulin receptors that  are missing the  C-terminal 112 amino 
acids of the cytoplasmic B subunit.  These  truncated receptors 
bind insulin  normally but lack  insulin  receptor tyrosine kinase 
activity (20). Similar studies in the line CHO.hIR, which 
expresses about 1.4 X lo4 human insulin  receptors/cell, 
showed slightly  less c-fos mRNA accumulation than the 
CH0.T cells; in  contrast, wild type  CHO cells showed essen- 
tially undetectable c-fos mRNA accumulation after insulin 
treatment, similar to that seen in 3T3-Ll fibroblasts (16) 
(results  not shown). 
In  contrast,  the  active  tumor-promoting phorbol ester  PMA 
caused a marked  accumulation of c-fos mRNA  after 30 min, 
in  both  the  CHO-T  and  CHO-T-t cells (Fig. 1) as well as in 
the CHO.hIR cells and wild type CHO cells (not shown). 
These  studies  established  that  the c-fos gene was still induci- 
ble by a stimulus  other  than  insulin  in  the  CH0.T-t cells. 
Treatment of the CH0.T cells with 16 PM PMA for 16 h 
depleted the cells of more than 94% of protein kinase C 
enzyme activity (control cells: 318 pmol/min/mg protein; 
CH0.T CH0.T-t 
‘C P 1°C P I ‘ 
-28s 
-18s 
FIG. 1. Levels of c-foe mRNA in CH0.T or CH0.T-t cells 
eXposed to PMA or insulin. Serum-deprived CH0.T or CH0.T-t 
cells were exposed to control conditions (C), PMA (P; 1.6 p~ in 
0.01% dimethyl sulfoxide), or insulin (k  10 milliunits/ml (about 70 
nM)) for 30 min. Total cellular RNA was then prepared from the 
cells, and  15  pg  were  loaded into each gel lane. The RNA was 
transferred to nitrocellulose and  used  for  Northern analysis of c-fos 
mRNA levels as described in the text. The markers indicate the 
positions of the major ribosomal  RNA species on the gel. 
PMA-pretreated cells: 18 pmol/min/mg  protein). In keeping 
with our previous results  in  3T3-Ll adipocytes  (16),  insulin 
(but  not  further  PMA) was still able to induce c-fos expression 
in  the  protein kinase  C-depleted cells (not shown). 
We next investigated the effects of insulin and phorbol 
esters  on  CHO-T cells which had been transfected with  plas- 
mid chloramphenicol acetyltransferase  constructions  contain- 
ing either  the  normal  murine c-fos upstream sequences from 
-356 to  +lo9 (-356 fos-chloramphenicol acetyltransferase) 
or the  same sequence in which G residues in positions -305 
and -306 in  the  top  strand,  and -314 and -313 in  the  bottom 
strand  had been changed to C residues by site-directed mu- 
tagenesis (2-4 pM12). These G  residues are  thought  to be in 
close contact with  a  nuclear  factor that  binds  to  this  site (18, 
19).  Expression of these fusion genes was evaluated in  tran- 
sient expression experiments using an RNase protection assay 
(Fig. 2 4 ) .  Each lane represents pooled RNA from 5 of 15 
dishes exposed to  the  same precipitate, thereby minimizing 
possible differences in transfection efficiency. As shown in 
Fig. 2A,  both  PMA  and insulin stimulated  the expression of 
the fusion gene containing  the normal c-fos sequences; quan- 
titation of these changes by densitometry revealed increases 
of approximately 3-fold in response to 45 min of treatment 
with PMA or insulin (Fig. 2B). However, the fusion gene 
containing  the  mutated bases in  the  SRE responded mini- 
mally to both  stimuli (Fig. 2, A and  B). Similar  results were 
obtained  in a second identical transfection experiment. Av- 
erages from the two experiments were as follows: plasmid 
-356 fos-chloramphenicol acetyltransferase, 3.3-fold stimu- 
lation with  PMA, 3.0-fold stimulation with  insulin; plasmid 
2-4 pM12, 31% stimulation with PMA, 3% stimulation  with 
insulin. No protected fragments were noted in RNA from 
insulin- or PMA-stimulated nontransfected CH0.T cells. 
However, several protected bands of larger apparent size 
shown in Fig. 2A were noted in RNA from the  transfected 
and  nontransfected cells as well as in mouse RNA. 
To ensure  that  the  transfection protocol did not adversely 
affect  hormonal stimulation of endogenous c-fos mRNA  ac- 
cumulation, we evaluated total cellular  RNA from both  sets 
of transfected cells by Northern blotting,  using a v-fos probe 
as described (16). Both  the undetectable c-fos mRNA levels 
in  the basal state  and  the increased accumulation of c-fos 
mRNA in response to PMA  and insulin were equivalent in 
both  sets of cells transfected with either  the normal or mutant 
plasmids (Fig. 2C). 
Nuclear extracts from the  CH0.T cells contained  factors, 
presumably  proteins, which bound  to  the 32P-labeled inserts 
containing 83 bp of either the normal or mutant c-fos se- 
quences, as assessed by gel shift analysis. However, only a 
single slowly migrating species bound uniquely to  the  normal 
plasmid insert when compared either to  the  insert from the 
mutant plasmid or a  slightly  larger  fragment from the vector, 
pUC 13 (Fig. 3). This  experiment showed that  the G residues 
required for biological activity were also  required for binding 
of this nuclear  factor.  Evaluation of this  factor from control 
CH0.T cells or those treated with either insulin or EGF 
revealed no  apparent increase or decrease in  the  amount of 
“P-labeled insert  shifted  into  the position of the unique  band 
(Fig. 3). In other experiments, treatment of the cells with 
either insulin (1 milliunit/ml) or PMA (1.6 pM)  for 30 min 
did not affect the  intensity of the specific shifted band on the 
autoradiographs  (data  not shown).  A  similar protein could be 
detected in nuclear extracts from 1321-N1 human astrocy- 
toma cells, in which c-fos is  also  rapidly induced by various 
stimuli (28) (Fig. 3). 
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FIG. 2. Induction  of  foe-chloramphenicol  acetyltransferase  fusion  genes  by PMAor insulin  in CH0.T 
cells.  CH0.T cells were tranfected with plasmids containing  either normal murine c-fos sequences (-356fos-CAT) 
or the same region of the fos gene carrying point  mutations  as described in the  text (2-4pM12). Forty-eight hours 
after  transfection the cells were deprived of serum for 16 h and  then exposed to control conditions (C), PMA (P; 
1.6 p~ in 0.01% dimethyl sulfoxide), or insulin (I; 10 milliunits/ml) for 45 min. Total RNA  was then prepared 
from five plates of cells for each condition and used for the analysis of induced transfected genes. In A is shown 
the RNase protection assay, in which the protected fragment from the fos-chloramphenicol acetyltransferase 
constructions is indicated with the arrow at  i t s  expected apparent size position of 128 bp. The positions of other 
size markers are indicated. RNase protection of murine RNA in the same assay revealed a major protected band 
of endogenous c-fos  mRNA at  110 bp, where there is no protected hamster species. Similarly, no RNA species of 
128 bp from nontransfected CH0.T cells was protected by the probe used. In B is shown a graphic representation 
of the densitometry tracing of the 128-bp protected fragment; abbreviations are  the same as in A. In C is shown 
Northern analysis of endogenous c-fos  mRNA  levels in the same RNA samples as used for the RNase protection 
assay described in A and B ;  15 pg  of total cellular RNA was loaded into each gel lane. Abbreviations are  the same 
as in the legend to Fig. 1 and in A above. 
DISCUSSION 
Extract CHO. T Extracts ,Extract, 
No 1321-N1 These studies  established several facts  bout the induction 
of c-fos by insulin and phorbol esters  in  these cells. First, the 
studies with the  CH0.T  and  CH0.T-t cells indicated that  the 
insulin induction of c-fos  mRNA. Induction did not occur in 
cells with similar numbers of truncated insulin receptors, 
which exhibit  similar amounts of insulin binding but essen- 
tially no insulin-stimulated receptor tyrosine kinase activity 
curred in normal cells and in  those  almost completely depleted 
of protein kinase C. Second, although  they  appear to  act by 
different  initial mechanisms and  their responses are additive 
in 3T3-Ll cells (16), insulin and PMA required the same 
intact sequences in the c-fos SRE (bases -299 to -320) in 
FIG. 3. Gel  shift  analysis of a nuclear  factor  from CH0.T order to induce c-fos transcription.  Mutation of four guanine 
Cells which  binds to the  normal  but  not  the  mutated  region of residues in this region that contact a nuclear factor (18, 19) 
the c-fos 5' flanking  element.  CH0.T cells and 1321-N1 human abolished induction by both stimuli. ~h~~~ mutations, Or 
conditions, insulin (10 milliunits/ml), or EGF (100 ng/ml) for 30 min. similar ones, also reduce c-fos induction by serum in 3T3 
astrocytoma cells were deprived of serum and then exposed to control 
Nuclear extracts were then prepared and used for DNA binding gel fibroblasts2 (30). We also demonstrated the existence Of a 
shift analyses as described in the text.  Probe I represents the probe nuclear factor, presumably a  protein, from CH0.T cells that 
derived from plasmid -356 fos-chloramphenicol acetyltransferase, interacted with  the SRE with similar specficity. However, we 
and probe 2 represents the probe of identical size from plasmid 2-4 could not demonstrate that exposure of the cells to insulin, 
pM12; both migrated to an identical position on the gel, as indicated 
by the arrow. Probe 3 is a 140-b~ fragment of the non-fos portion of EGF, or PMA caused changes in the apparent  affinity ofthis 
plasmid -356 fos-chloramphenicol acetyltransferase, which contains factor to  the c-fos sequences, in keeping with previous studies 
only sequences of the pUC 12 vector; its migration position is indi- of semm-induced c-fos expression in HeLa cells (18, 29) but 
probe used to bind to  the nuclear extract  in that lane. The arrow to 
cated by the arrow. The numbers above each gel lane indicate the differing from recent studies involving EGF-induced c-fos 
the right of the autoradiograph points to a single band in both cell expression in A431 cells (29). The reasons for these  differ- 
types which appears to bind specifically to probe 1 but not  to probe ences are  not clear but may  be  resolved when purified sRE 
2 or 3. binding proteins and antibodies to them become available. 
To our knowledge, insulin-stimulated c-fos transcription is 
-
tontrol Insulin EGF ' Control 
Probe- 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3  
""
'7: , -,- presence of normal insulin receptors was required for the 
Probe -4'
I (20). As in  our previous studies (16), the insulin effect OC- 
Probe 1,2- 
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the earliest stimulatory transcriptional response to insulin 
yet reported. In addition to the present findings and our 
previous studies in  3T3-Ll adipocytes, we have noted insulin- 
stimulated c-fos induction in two other insulin-responsive cell 
types, H4IIE rat hepatoma cells and BC3H1 mouse muscle 
cells.3 Similar findings in Reuber H35 rat hepatoma cells have 
been reported recently (31).  Taken together, these observa- 
tions suggest that  the insulin induction of c-fos might be an 
early physiological response in many insulin-sensitive tissues, 
perhaps affecting later  insulin-stimulated  transcriptional re- 
sponses, since data identifying the c-fos protein  as  a trans- 
acting regulator of gene transcription  are fairly strong (32- 
35). For these reasons, we believe that  the protein(s) involved 
in  the insulin-stimulated  transcription of c-fos,  possibly the 
same as those involved in the response to activators of protein 
kinase C, will prove to be important early targets of some 
insulin-stimulated cellular pathway, perhaps  through phos- 
phorylation-dephosphorylation reactions. 
Previous studies (17-19, 36) established that a region of 
dyad symmetry with properties of a viral enhancer located 
between -320 to -299 relative to  the transcription  initiation 
site in the human c-fos  gene  were required for serum induction 
of the c-fos  gene in 3T3 fibroblasts. However, a sequence from 
-351 to -337 in the human c-fos gene has recently been 
shown to bind a PDGF-inducible factor in BALBJc-3T3 cells, 
a factor which was not induced by insulin or PMA (37). 
Binding sites  in the c-fos  gene for other nuclear factors have 
been identified (19, 38). 
Serum is a complex mixture of potentially inducing com- 
pounds including PDGF, which can activate c-fos expression 
by protein kinase C-dependent and -independent pathways 
(16) as well as by cyclic AMP-dependent pathways (39),  and 
insulin, which appears to  act in 3T3-Ll cells through  a protein 
kinase C- and CAMP-independent pathway (16, 26). It ap- 
pears from the present work that  at least two components of 
serum, insulin and PDGF, can induce c-fos transcription 
through involvement of the SRE, with PDGF acting, at least 
in part,  through activation of protein kinase C in this case. 
Whether  other  PDGF-activated pathways, such as activation 
of the CAMP-dependent protein kinase, will induce c-fos 
expression through other sequences (37) remains to be deter- 
mined. 
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